ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib

Press/Media: Expert Comment

PeriodMay 20 2020

Media coverage

18

Media coverage